By LSE RNS
London, 22 May 2019
NOTIFICATION OF TRANSACTIONS OF DIRECTORS/PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY AND CONNECTED PERSONS
The notification set out below is provided in accordance with the requirements of the EU Market Abuse Regulation.
1. |
Details of the person discharging managerial responsibilities / person closely associated |
|||||||||
a) |
Name |
Nikoloz Gamkrelidze |
||||||||
2. |
Reason for the notification |
|||||||||
a) |
Position / status |
PDMR, CEO |
||||||||
b) |
Initial notification / amendment |
Initial notification |
||||||||
3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||||||
a) |
Name |
Georgia Healthcare Group PLC |
||||||||
b) |
LEI: |
213800RJGJDDZENQER80 |
||||||||
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||||||
a) |
Description of the financial instrument, type of instrument
Identification Code
|
Nil cost options over ordinary shares of £0.01 each in Georgia Healthcare Group PLC
GB00BYSS4K11
|
||||||||
b) |
Nature of the transaction |
Grant of nil-cost options over ordinary shares in respect of deferred salary shares for the 2018 work year pursuant to the executive equity compensation plan. 20% of the salary shares will vest in each of the second, third and fourth years following the work year, and the remaining 40% vest in the fifth year following the work year, subject to the terms of his service agreement. |
||||||||
c) |
Price(s) and volume(s) |
|
||||||||
d) |
Aggregated information |
|
||||||||
|
Aggregated volume
|
Grant of 175,000 nil-cost options over ordinary shares in respect of deferred salary shares for the 2018 work year pursuant to the executive equity compensation plan. |
||||||||
|
Aggregated price |
n/a |
||||||||
|
|
|
||||||||
e) |
Dates of the transaction |
20 May 2019 |
||||||||
f)
|
Place of the transaction |
Outside of a trading venue |
1. |
Details of the person discharging managerial responsibilities / person closely associated |
|||||||||
a) |
Name |
Irakli Gogia |
||||||||
2. |
Reason for the notification |
|||||||||
a) |
Position / status |
PDMR, Deputy CEO - Finance and Operations |
||||||||
b) |
Initial notification / amendment |
Initial notification |
||||||||
3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||||||
a) |
Name |
Georgia Healthcare Group PLC |
||||||||
b) |
LEI: |
213800RJGJDDZENQER80 |
||||||||
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||||||
a) |
Description of the financial instrument, type of instrument
Identification Code
|
Nil cost options over ordinary shares of £0.01 each in Georgia Healthcare Group PLC
GB00BYSS4K11
|
||||||||
b) |
Nature of the transaction |
Grant of nil-cost options over ordinary shares in respect of deferred salary shares for the 2018 work year pursuant to the executive equity compensation plan. 20% of the salary shares will vest in each of the second, third and fourth years following the work year, and the remaining 40% vest in the fifth year following the work year, subject to the terms of his service agreement. |
||||||||
c) |
Price(s) and volume(s) |
|
||||||||
d) |
Aggregated information |
|
||||||||
|
Aggregated volume
|
Grant of 53,000 nil-cost options over ordinary shares in respect of deferred salary shares for the 2018 work year pursuant to the executive equity compensation plan. |
||||||||
|
Aggregated price |
n/a |
||||||||
|
|
|
||||||||
e) |
Dates of the transaction |
20 May 2019 |
||||||||
f)
|
Place of the transaction |
Outside of a trading venue |
1. |
Details of the person discharging managerial responsibilities / person closely associated |
|||||||||
a) |
Name |
Giorgi Mindiashvili |
||||||||
2. |
Reason for the notification |
|||||||||
a) |
Position / status |
PDMR, Chief Operating Officer - Hospitals |
||||||||
b) |
Initial notification / amendment |
Initial notification |
||||||||
3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||||||
a) |
Name |
Georgia Healthcare Group PLC |
||||||||
b) |
LEI: |
213800RJGJDDZENQER80 |
||||||||
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||||||
a) |
Description of the financial instrument, type of instrument
Identification Code
|
Nil cost options over ordinary shares of £0.01 each in Georgia Healthcare Group PLC
GB00BYSS4K11
|
||||||||
b) |
Nature of the transaction |
Grant of nil-cost options over ordinary shares in respect of deferred salary shares for the 2018 work year pursuant to the executive equity compensation plan. 20% of the salary shares will vest in each of the second, third and fourth years following the work year, and the remaining 40% vest in the fifth year following the work year, subject to the terms of his service agreement. |
||||||||
c) |
Price(s) and volume(s) |
|
||||||||
d) |
Aggregated information |
|
||||||||
|
Aggregated volume
|
Grant of 53,000 nil-cost options over ordinary shares in respect of deferred salary shares for the 2018 work year pursuant to the executive equity compensation plan. |
||||||||
|
Aggregated price |
n/a |
||||||||
|
|
|
||||||||
e) |
Dates of the transaction |
20 May 2019 |
||||||||
f)
|
Place of the transaction |
Outside of a trading venue |
1. |
Details of the person discharging managerial responsibilities / person closely associated |
|||||||||
a) |
Name |
Nikoloz Gamkrelidze |
||||||||
2. |
Reason for the notification |
|||||||||
a) |
Position / status |
PDMR, CEO |
||||||||
b) |
Initial notification / amendment |
Initial notification |
||||||||
3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||||||
a) |
Name |
Georgia Healthcare Group PLC |
||||||||
b) |
LEI: |
213800RJGJDDZENQER80 |
||||||||
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||||||
a) |
Description of the financial instrument, type of instrument
Identification Code
|
Nil cost options over ordinary shares of £0.01 each in Georgia Healthcare Group PLC
GB00BYSS4K11
|
||||||||
b) |
Nature of the transaction |
Grant of nil-cost options over ordinary shares in respect of discretionary deferred shares for the 2018 work year pursuant to the executive equity compensation plan.
Shares will vest on a straight-line basis in each of the second, third and fourth years following the work year, subject to the terms of his service agreement. |
||||||||
c) |
Price(s) and volume(s) |
|
||||||||
d) |
Aggregated information |
|
||||||||
|
Aggregated volume
|
Grant of 111,301 nil-cost options over ordinary shares in respect of discretionary deferred shares for the 2018 work year pursuant to the executive equity compensation plan.
|
||||||||
|
Aggregated price |
n/a |
||||||||
|
|
|
||||||||
e) |
Dates of the transaction |
20 May 2019 |
||||||||
f)
|
Place of the transaction |
Outside of a trading venue |
1. |
Details of the person discharging managerial responsibilities / person closely associated |
|||||||||
a) |
Name |
Irakli Gogia |
||||||||
2. |
Reason for the notification |
|||||||||
a) |
Position / status |
PDMR, Deputy CEO - Finance and Operations |
||||||||
b) |
Initial notification / amendment |
Initial notification |
||||||||
3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||||||
a) |
Name |
Georgia Healthcare Group PLC |
||||||||
b) |
LEI: |
213800RJGJDDZENQER80 |
||||||||
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||||||
a) |
Description of the financial instrument, type of instrument
Identification Code
|
Nil cost options over ordinary shares of £0.01 each in Georgia Healthcare Group PLC
GB00BYSS4K11
|
||||||||
b) |
Nature of the transaction |
Grant of nil-cost options over ordinary shares in respect of discretionary deferred shares for the 2018 work year pursuant to the executive equity compensation plan.
Shares will vest on a straight-line basis in each of the second, third and fourth years following the work year, subject to the terms of his service agreement. |
||||||||
c) |
Price(s) and volume(s) |
|
||||||||
d) |
Aggregated information |
|
||||||||
|
Aggregated volume
|
Grant of 68,443 nil-cost options over ordinary shares in respect of discretionary deferred shares for the 2018 work year pursuant to the executive equity compensation plan.
|
||||||||
|
Aggregated price |
n/a |
||||||||
|
|
|
||||||||
e) |
Dates of the transaction |
20 May 2019 |
||||||||
f)
|
Place of the transaction |
Outside of a trading venue |
1. |
Details of the person discharging managerial responsibilities / person closely associated |
|||||||||
a) |
Name |
Giorgi Mindiashvili |
||||||||
2. |
Reason for the notification |
|||||||||
a) |
Position / status |
PDMR, Chief Operating Officer - Hospitals |
||||||||
b) |
Initial notification / amendment |
Initial notification |
||||||||
3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||||||
a) |
Name |
Georgia Healthcare Group PLC |
||||||||
b) |
LEI: |
213800RJGJDDZENQER80 |
||||||||
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||||||
a) |
Description of the financial instrument, type of instrument
Identification Code
|
Nil cost options over ordinary shares of £0.01 each in Georgia Healthcare Group PLC
GB00BYSS4K11
|
||||||||
b) |
Nature of the transaction |
Grant of nil-cost options over ordinary shares in respect of discretionary deferred shares for the 2018 work year pursuant to the executive equity compensation plan.
Shares will vest on a straight-line basis in each of the second, third and fourth years following the work year, subject to the terms of his service agreement. |
||||||||
c) |
Price(s) and volume(s) |
|
||||||||
d) |
Aggregated information |
|
||||||||
|
Aggregated volume
|
Grant of 56,365 nil-cost options over ordinary shares in respect of discretionary deferred shares for the 2018 work year pursuant to the executive equity compensation plan.
|
||||||||
|
Aggregated price |
n/a |
||||||||
|
|
|
||||||||
e) |
Dates of the transaction |
20 May 2019 |
||||||||
f)
|
Place of the transaction |
Outside of a trading venue |
1. |
Details of the person discharging managerial responsibilities / person closely associated |
|||||||||
a) |
Name |
Enrico Beridze, Head of Business Development and Strategic Marketing |
||||||||
2. |
Reason for the notification |
|||||||||
a) |
Position / status |
PDMR |
||||||||
b) |
Initial notification / amendment |
Initial notification |
||||||||
3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||||||
a) |
Name |
Georgia Healthcare Group PLC |
||||||||
b) |
LEI: |
213800RJGJDDZENQER80 |
||||||||
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||||||
a) |
Description of the financial instrument, type of instrument
Identification Code
|
Nil cost options over ordinary shares of £0.01 each in Georgia Healthcare Group PLC
GB00BYSS4K11
|
||||||||
b) |
Nature of the transaction |
Grant of nil-cost options over ordinary shares in respect of discretionary deferred shares for the 2018 work year pursuant to the executive equity compensation plan.
Shares will vest on a straight-line basis in each of the second, third and fourth years following the work year, subject to the terms of his service agreement. |
||||||||
c) |
Price(s) and volume(s) |
|
||||||||
d) |
Aggregated information |
|
||||||||
|
Aggregated volume
|
Grant of 90,000 nil-cost options over ordinary shares in respect of discretionary deferred shares for the 2018 work year pursuant to the executive equity compensation plan.
|
||||||||
|
Aggregated price |
n/a |
||||||||
|
|
|
||||||||
e) |
Dates of the transaction |
20 May 2019 |
||||||||
f)
|
Place of the transaction |
Outside of a trading venue |
|
|
|
|
|
Name of authorised official of issuer responsible for making notification:
Link Company Matters Limited, Company Secretary
You are here: news > regulatory news